Jeanne M. DeCara

TL;DR: The noninvasive evaluation of LVEF has gained importance, and notwithstanding the limitations of the techniques used for its calculation, has emerged as the most widely used strategy for monitoring the changes in cardiac function, both during and after the administration of potentially car- diotoxic cancer treatment.

TL;DR: The non-invasive evaluation of LVEF has gained importance, and notwithstanding the limitations of the techniques used for its calculation, has emerged as the most widely used strategy for monitoring the changes in cardiac function, both during and after the administration of potentially cardiotoxic cancer treatment.

TL;DR: The author’s biography is based on a manuscript originally written by Gordon C. Dickinson in 2012 and then edited by David I. Dickinson.

TL;DR: Common CV toxicities related to cancer therapy are defined, along with suggested strategies for prevention, detection and treatment, and guidance regarding prevention, screening, monitoring and treatment of CV toxicity is provided.

TL;DR: Echocardiographic contrast perfusion imaging aids in the differentiation of cardiac masses, with malignant and vascular tumors hyper-enhancing, whereas stromal tumors and thrombi hypo-enhanced.